Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
1 May 2018
Haris Chaudhry, InnovaDerma’s executive chairman said: "I am delighted to be launching Prolong, the world's only FDA-cleared medical device for premature ejaculation in the United States and Australia together with smilingdick.com.”
http://www.proactiveinvestors.co.uk/companies/news/196172/innovaderma-launches-fda-cleared-premature-ejaculation-medical-device-in-the-usa-australia-196172.html
InnovaDerma launches FDA-cleared premature ejaculation medical device in the USA, Australia
16:07 01 May 2018
The Skinny Tan group said the launch of Prolong is being supported by a highly creative marketing campaign, including a website smilingdick.com
Erectile disfunction
> https://goo.gl/dvTdci <
Innovaderma said it is seeking CE Mark regulatory approval for Prolong and once obtained, the device will also be launched in the UK and Europe
InnovaDerma (LON:IDP), the UK developer of life sciences, beauty and personal care products, said it has now launched Prolong - the world's only FDA-cleared medical device for premature ejaculation - in the United States and Australia.
The Skinny Tan group said the launch is being supported by a highly creative marketing campaign, including a website smilingdick.com.
InnovaDerma said it conducted in-depth research with 4,000 men and women across Australia and the United States and the findings form the basis of the launch of Prolong and smilingdick.com.
It added that the most revealing findings were that one in two men in the United States believe they suffer from premature ejaculation and in Australia, one in three.
The company said it is seeking CE Mark regulatory approval for Prolong and once obtained, the device will also be launched in the UK and Europe.
Haris Chaudhry, InnovaDerma’s executive chairman said: "I am delighted to be launching Prolong, the world's only FDA-cleared medical device for premature ejaculation in the United States and Australia together with smilingdick.com.”
He added: “Through Prolong and Smiling Dick, we aim to provide a non-prescription solution with long term benefits and a platform to help people feel open and supported in what should be a healthy and normal dialogue."